Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Other Non-Current Liabilities (2022 - 2025)

Historic Other Non-Current Liabilities for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Envoy Medical's Other Non-Current Liabilities fell 1248.05% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 1248.05%. This contributed to the annual value of $1.8 million for FY2024, which is 790.43% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Other Non-Current Liabilities is $1.7 million, which was down 1248.05% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Other Non-Current Liabilities ranged from a high of $34.0 million in Q4 2022 and a low of $144770.0 during Q2 2023
  • Over the past 4 years, Envoy Medical's median Other Non-Current Liabilities value was $1.8 million (recorded in 2024), while the average stood at $4.8 million.
  • In the last 5 years, Envoy Medical's Other Non-Current Liabilities tumbled by 9433.95% in 2023 and then soared by 122831.39% in 2024.
  • Envoy Medical's Other Non-Current Liabilities (Quarter) stood at $34.0 million in 2022, then tumbled by 94.34% to $1.9 million in 2023, then fell by 7.9% to $1.8 million in 2024, then dropped by 4.97% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $1.7 million for Q2 2025, and $1.8 million during Q1 2025.